Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu01:29

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters01:16

Pharmacogenetics of Drug Transporters: P-Glycoprotein and Solute Carrier Transporters

The pharmacogenetics of drug transporters is increasingly recognized as a critical factor influencing interindividual variability in drug absorption, distribution, and elimination. These membrane-bound proteins regulate drugs' movement across cellular barriers by actively pumping them out (efflux) or facilitating their uptake (influx). Among the major transporter families, ATP-binding cassette (ABC) and solute carrier (SLC) transporters play particularly prominent roles. Genetic polymorphisms...
Cholesterol: Significance and Regulation01:29

Cholesterol: Significance and Regulation

Although not a source of energy, cholesterol plays a significant role as a foundational structure for bile salts, steroid hormones, and vitamin D, as well as being a crucial component of plasma membranes. Approximately 15% of blood cholesterol is derived from our diet, with the remainder synthesized from acetyl CoA by the liver and intestines. Cholesterol is eliminated from the body through its conversion into bile salts, which are eventually discarded in the feces.
Considering cholesterol and...
Pleiotropy01:33

Pleiotropy

Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Revista chilena de pediatria·2018
Same author

[Therapeutic potential of Cannabis sativa].

Revista medica de Chile·2017
Same author

[Origins and situation of phytotherapy in Chile].

Revista medica de Chile·2011
Same author

[General aspects of homeopathy].

Revista medica de Chile·2009

Related Experiment Video

Updated: Jul 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

[Pleiotropic effects of statins].

Sigrid Mennickent C1, Marisol Bravo D, Carlos Calvo M

  • 1Departamento de Farmacia, Facultad de Farmacia, Universidad de Concepción, Casilla 237, Concepción, Chile. smennick@udec.cl

Revista Medica De Chile
|September 5, 2008
PubMed
Summary

Lowering LDL cholesterol with statins significantly reduces coronary heart disease (CHD) risk and mortality. This review explores statin pharmacology and their additional beneficial effects beyond cholesterol reduction.

Area of Science:

  • Cardiology
  • Pharmacology

Background:

  • Elevated serum cholesterol, particularly LDL, is a primary driver of coronary heart disease (CHD).
  • Numerous studies link high cholesterol levels to increased CHD incidence and atherosclerosis progression.

Purpose of the Study:

  • To review the pharmacology of HMG-CoA reductase inhibitors (statins).
  • To discuss the pleiotropic (additional) effects of statins beyond cholesterol reduction.

Main Methods:

  • Analysis of epidemiologic and clinical trial data on statin efficacy.
  • Review of pharmacological mechanisms and clinical outcomes associated with statin use.

Main Results:

  • Decreasing LDL-cholesterol concentration with statins reduces CHD incidence, atherosclerosis progression, morbidity, and mortality.

Related Experiment Videos

Last Updated: Jul 2, 2026

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles
09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

  • A 1% reduction in LDL-cholesterol may yield a 1% decrease in CHD incidence.
  • Pooled data analysis showed statin treatment for 5.4 years reduced major coronary events by 31% and total mortality by 21%.

    • Conclusions:

    • Statins are effective in managing hypercholesterolemia and reducing cardiovascular events.
    • The pleiotropic effects of statins warrant further investigation for comprehensive cardiovascular risk management.